These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20571095)

  • 1. Proteomic biomarkers in diabetic nephropathy--reality or future promise?
    Mischak H; Rossing P
    Nephrol Dial Transplant; 2010 Sep; 25(9):2843-5. PubMed ID: 20571095
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteomic approaches for discovering biomarkers of diabetic nephropathy.
    Ben Ameur R; Molina L; Bolvin C; Kifagi C; Jarraya F; Ayadi H; Molina F; Granier C
    Nephrol Dial Transplant; 2010 Sep; 25(9):2866-75. PubMed ID: 20472580
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Qualitative study of proteinuria in diabetic nephropathy].
    Faure Nogueras E; Blasco Comenge MC; Guillén Martínez G
    An Med Interna; 1991 Jul; 8(7):333-5. PubMed ID: 1932490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
    Meier M; Kaiser T; Herrmann A; Knueppel S; Hillmann M; Koester P; Danne T; Haller H; Fliser D; Mischak H
    J Diabetes Complications; 2005; 19(4):223-32. PubMed ID: 15993357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip.
    Wu J; Chen YD; Yu JK; Shi XL; Gu W
    Diabetes Res Clin Pract; 2011 Feb; 91(2):213-9. PubMed ID: 21237525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary type IV collagen excretion predicts subsequent declining renal function in type 2 diabetic patients with proteinuria.
    Katavetin P; Katavetin P; Susantitaphong P; Townamchai N; Tiranathanagul K; Tungsanga K; Eiam-Ong S
    Diabetes Res Clin Pract; 2010 Aug; 89(2):e33-5. PubMed ID: 20542586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P; Chan SP
    Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A further investigation on a MALDI-based method for evaluation of markers of renal damage.
    Lapolla A; Molin L; Sechi A; Cosma C; Ragazzi E; Seraglia R; Traldi P
    J Mass Spectrom; 2009 Dec; 44(12):1754-60. PubMed ID: 19852035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
    Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary biomarkers involved in type 2 diabetes: a review.
    Matheson A; Willcox MD; Flanagan J; Walsh BJ
    Diabetes Metab Res Rev; 2010 Mar; 26(3):150-71. PubMed ID: 20222150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteinuria in diabetes mellitus--a prognostic indicator even in type II?].
    Janka HU
    Dtsch Med Wochenschr; 1987 Sep; 112(38):1443-4. PubMed ID: 3622291
    [No Abstract]   [Full Text] [Related]  

  • 17. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
    Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
    J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
    Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
    Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of macroalbuminuria with pentoxifylline in diabetic nephropathy. Report of three cases.
    Gorson DM
    Diabetes Care; 1998 Dec; 21(12):2190-1. PubMed ID: 9839116
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic strategy to monitor diabetic nephropathy.
    Rowe DJ; Twyman S
    Kidney Int Suppl; 1994 Nov; 47():S109-10. PubMed ID: 7869658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.